Allogene Therapeutics
ALLO
#8751
Rank
NZ$0.39 B
Marketcap
NZ$1.15
Share price
-5.88%
Change (1 day)
-47.62%
Change (1 year)

Earnings for Allogene Therapeutics (ALLO)

Earnings in 2026 (TTM): -NZ$0.29 Billion

According to Allogene Therapeutics 's latest financial reports the company's current earnings are NZ$4.64 Million. In 2025 the company made an earning of -NZ$0.35 Billion, an increase over its 2024 earnings that were of -NZ$0.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allogene Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.29 Billion-17.75%
2025 -NZ$0.35 Billion-26.13%
2024 -NZ$0.47 Billion-18.12%
2023 -NZ$0.58 Billion-6.44%
2022 -NZ$0.62 Billion31.14%
2021 -NZ$0.47 Billion2.23%
2020 -NZ$0.46 Billion25.98%
2019 -NZ$0.37 Billion-4.68%
2018 -NZ$0.39 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.29 Billion-4.91%๐Ÿ‡บ๐Ÿ‡ธ USA